Barely Significant
← all excerpts

The HBP Pathway Inhibitor FR054 Enhances Temozolomide Sensitivity in Glioblastoma Cells by Promoting Ferroptosis and Inhibiting O-GlcNAcylation.

CNS Neurosci Ther · 2025 · PMC12329428 · PMID 40772310

Europe PMCDOI
1
hedged sentence
0.0800
closest p · 1.6× alpha
0.0800
boldest claim

The sentences

marginally significantp = 0.08so close (0.05 < p ≤ 0.1)
Notably, the TMZ + FR054 high group showed a marginally significant reduction in tumor fluorescence intensity compared to TMZ alone ( p = 0.08).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.